Amphastar Pharmaceuticals Company Profile (NASDAQ:AMPH)

Analyst Ratings

Consensus Ratings for Amphastar Pharmaceuticals (NASDAQ:AMPH) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $18.00 (8.63% upside)

Analysts' Ratings History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Show:
DateFirmActionRatingPrice TargetActions
6/28/2016BMO Capital MarketsInitiated CoverageMarket Perform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Needham & Company LLCLower Price TargetBuy$21.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Raymond James Financial Inc.Lower Price Target$23.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Wells Fargo & Co.Initiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Jefferies GroupLower Price TargetBuy$18.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/10/2016        
5/9/2016Q1($0.03)$0.12$62.00 million$59.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2016Q415($0.04)$0.19$64.48 million$76.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2015Q315($0.08)($0.01)$19.49 million$63.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2015Q215($0.11)($0.09)$19.49 million$53.85 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2015Q115($0.17)($0.01)$45.87 million$56.89 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/24/2015Q414($0.06)($0.03)$54.90 million$55.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2014Q314($0.09)($0.07)$45.89 million$59.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014($0.11)$0.02ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Amphastar Pharmaceuticals (NASDAQ:AMPH)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/18/2016William J PetersCFOSell2,297$17.76$40,794.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Rong ZhouEVPSell1,551$15.85$24,583.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2016Richard K PrinsDirectorSell7,500$15.94$119,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Jason B ShandellPresidentSell9,904$16.43$162,722.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2016William J PetersCFOSell2,297$16.00$36,752.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Jason B ShandellPresidentSell1,074$15.60$16,754.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Diane G GerstEVPSell1,427$13.97$19,935.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Richard K PrinsDirectorSell3,200$13.56$43,392.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/19/2016Diane G GerstEVPSell21,244$12.89$273,835.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Diane G GerstEVPSell15,637$12.83$200,622.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2016Richard K PrinsDirectorSell2,400$11.25$27,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2015Stephen B. ShohetDirectorSell30,770$14.19$436,626.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Howard LeeDirectorSell38,462$14.34$551,545.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Rong ZhouEVPSell772$14.29$11,031.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Jack Y ZhangCEOSell63,300$14.25$902,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Jack Y ZhangCEOSell68,117$14.71$1,002,001.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Jack Y ZhangCEOSell38,583$15.45$596,107.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Richard K PrinsDirectorSell9,100$14.66$133,406.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Richard K. PrinsDirectorSell5,400$14.70$79,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2015Michael A ZasloffDirectorSell7,692$17.41$133,917.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2015Rong ZhouEVPSell1,000$16.48$16,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Jack Y ZhangCEOSell45,382$16.29$739,272.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Jack Y ZhangCEOSell160,495$16.23$2,604,833.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Jack Y ZhangCEOSell193,758$16.43$3,183,443.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2015Richard K PrinsDirectorSell29,452$14.77$435,006.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2015Richard K PrinsDirectorSell3,000$14.94$44,820.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2015Marilyn J PurchaseVPSell28,000$15.79$442,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Diane G GerstSVPSell10,000$15.79$157,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Howard LeeDirectorBuy6,000$10.84$65,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Michael A ZasloffDirectorBuy3,500$10.00$35,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Richard K PrinsDirectorBuy4,000$10.02$40,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Floyd F PetersenDirectorBuy3,200$10.35$33,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Amphastar Pharmaceuticals (NASDAQ:AMPH)
DateHeadline
07/28/16 11:09 AMMomenta Wins Dismissal Of Blood-Clot Drug Antitrust Suit
07/26/16 08:30 AMZacks.com featured highlights: Apogee Enterprises, NTT DOCOMO, Barnes & Noble, Amphaster Pharmaceuticals and Monart Casino & Resort -
07/22/16 07:29 PMShares Stumbling of Late: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - TGP
07/22/16 10:39 AMEarnings Focus and Crowd Sourced Sentiment Review for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - TGP
07/22/16 10:39 AMCould Amphastar Pharmaceuticals Inc Lose its Strength? The Stock Reaches 52-Week High - Consumer Eagle
07/20/16 10:35 AMInsiders Selling, Short Interest Growing Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Finance Daily
07/19/16 07:54 PMWilliam Peters Sold 2297 shares of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) in an Insider Trade - Consumer Eagle
07/19/16 02:28 PMAmphastar Pharmaceuticals Incorporated (NASDAQ:AMPH) Sellers Increased By 7.97% Their Shorts - Consumer Eagle
07/19/16 02:28 PMEquity Roundup: Stock Performance Focus on Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Press Telegraph
07/18/16 02:31 PMOption Market: Amphastar Pharmaceuticals Inc Risk Hits An Inflection Point - CML News
07/18/16 07:18 AMReview on Stock Valuation for: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - TGP
07/18/16 07:18 AMShare Performance Summary for: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Press Telegraph
07/17/16 08:01 AMAs need grows for painkiller overdose treatment, companies raise prices -
07/16/16 10:53 AMCrowd Rating and Earnings Recap for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Telanagana Press
07/16/16 10:53 AMAmphastar Pharmaceuticals Incorporated (NASDAQ:AMPH) Sellers Covered 15.28% of Their Shorts - Consumer Eagle
07/14/16 02:31 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 10:44 AMStock Providing Gains on the Month for Investors: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Telanagana Press
07/13/16 10:44 AMAmphastar Pharmaceuticals Incorporated (NASDAQ:AMPH) Short Interest Decreased By 15.28% - Consumer Eagle
07/12/16 02:42 PMAmphastar Pharmaceuticals Inc versus Heska Corporation Head to Head Compare - CML News
07/12/16 07:15 AMTrading Performance and Target Watch for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Press Telegraph
07/11/16 07:31 PMAmphastar Pharmaceuticals (NASDAQ:AMPH) 2016 Q1 Sentiment Change - Consumer Eagle
07/11/16 02:27 PMCompany Stock Focus for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Which Way Will Shares Head? - Press Telegraph
07/11/16 07:16 AMShare Valuation Recap for: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Telanagana Press
07/11/16 07:16 AMStock on the Rise for the Quarter: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Engelwood Daily
07/11/16 07:16 AMStock Performance Rundown on: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Press Telegraph
07/10/16 02:27 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Broker Price Targets For The Coming Week - Fiscal Standard
07/10/16 07:13 AMHow Many Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)'s Analysts Are Bullish? - Engelwood Daily
07/08/16 10:31 AMWall Street Ratings and Target Price Views on Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Telanagana Press
07/07/16 07:45 PMSmithfield’s Nationwide “Helping Hungry Homes” Tour Visits Cincinnati to Donate More Than 25,000 Pounds of Protein to the Freestore Foodbank
07/07/16 03:19 PMAMPHASTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Mate -
07/07/16 02:28 PMStock Expected to Grow at an Accelerated Rate: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Telanagana Press
07/06/16 08:14 PMBMO Capital Initiates Coverage on Amphastar Pharmaceuticals Inc to Market Perform - TheFounders Daily
07/06/16 07:18 AMCan Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Improve on the Earnings Front? - Engelwood Daily
07/06/16 07:18 AMStock Accelerating: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Telanagana Press
07/06/16 07:18 AMStock Rating Watch and Earnings Insight for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Press Telegraph
07/04/16 02:26 PMShares With YTD Gains: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Telanagana Press
07/04/16 01:33 AMAggregated Micro Power Holdings Plc :AMPH-GB: Earnings Analysis: For the six months ended December 31, 2015 : July 4, 2016 -
07/04/16 12:48 AMAggregated Micro Power Holdings Plc :AMPH-GB: Earnings Analysis: 2015 By the Numbers : July 4, 2016 -
07/03/16 07:15 AMStock Valuation in Review: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Telanagana Press
07/01/16 02:28 PMSell-Side Recommendation & Price Target Projections on Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Telanagana Press
06/30/16 02:36 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Company Rating and Target Watch - Telanagana Press
06/29/16 02:28 PMBMO Capital Starts Coverage on Amphastar Pharmaceuticals, Inc. (AMPH) Giving It An Initial Rating Of "Market Perform" - Finance Daily
06/29/16 10:42 AMAmphastar Pharmaceuticals Incorporated (NASDAQ:AMPH) Short Interest Decreased By 15.28% - Engelwood Daily
06/28/16 02:42 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Earnings Glance and Target Price Review - Engelwood Daily
06/25/16 02:29 PMAnalyst's Ratings Review: Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) - iStreetWire
06/24/16 02:27 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Updated Price Targets - FTSE News
06/23/16 09:52 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) headlining after earnings - iStreetWire
06/21/16 07:14 AMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Current Analyst Ratings - Fiscal Standard
06/17/16 10:23 AMTrade-Ideas: Amphastar Pharmaceuticals (AMPH) Is Today's Weak On High Relative Volume Stock - TheStreet.com
06/14/16 07:15 AMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Trading Down – Insiders Are Selling

Social

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals logoAmphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable and inhalation products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The Company manufactures and sells approximately 20 products. Additionally, the Company is developing a portfolio of approximately 10 generic abbreviated new drug applications (ANDA), over three generic biosimilar and over six injectable and inhalation product candidates.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AMPH
  • CUSIP:
Key Metrics:
  • Previous Close: $16.57
  • 50 Day Moving Average: $16.40
  • 200 Day Moving Average: $13.48
  • P/E Ratio: 8220.00
  • P/E Growth: 5.52
  • Market Cap: $737.25M
  • Beta: 1.95
  • Current Year EPS Consensus Estimate: $0.05 EPS
  • Next Year EPS Consensus Estimate: $0.47 EPS
Additional Links:
Amphastar Pharmaceuticals (NASDAQ:AMPH) Chart for Thursday, July, 28, 2016